Here’s Why BofA Cut International Flavors & Fragrances (IFF) to Underperform

BofA downgraded International Flavors & Fragrances (IFF) to Underperform. The Nasdaq fell 5.52% in its worst day in 19 months, with AI-linked stocks hit hardest due to regulatory concerns. A strong jobs report increased Fed rate hike expectations to 78% for December.

Original reporting
Published Nov 8, 2026, 8:26 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 8, 2026, 8:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Here’s Why BofA Cut International Flavors & Fragrances (IFF) to Underperform — source image
Decision brief

The 30-second read

$IFFBearishLow
01

Why it matters

The downgrade adds to negative sentiment in a market already pressured by macro concerns.

02

Market read

The downgrade may contribute to further weakness in IFF and potentially affect related specialty chemicals stocks.

03

What to watch

Recent contract wins or cost‑saving initiatives that were not highlighted in the downgrade rationale.

Relevance 4/10Novelty 2/10Timing: none

Background

The article lists IFF among 10 high‑profile stocks downgraded by top analysts, noting a broad market sell‑off.

Company-level read

Ticker impact

$IFFBearishMedium confidence
Context

BofA downgraded International Flavors & Fragrances (IFF) to Underperform.

Expected impact

likely downward pressure as investors price in the downgrade

Evidence & confidence

Analyst downgrades historically lead to short-term price declines, especially when no offsetting news is present.

Market effects

Potential drag on the specialty chemicals sector as peers may be re‑rated.

Limited to U.S. markets where IFF is listed.

Minimal global impact; primarily a U.S. equity analyst note.

Counterpoint

Some investors may view the downgrade as an overreaction and see buying opportunity if fundamentals remain strong.

Key entities

  • International Flavors & Fragrances

    U.S. specialty chemicals maker (ticker IFF).

  • Bank of America

    Research firm that issued the Underperform rating.

Related articles

$IFFMedAI 8/10

International Flavors & Fragrances Q3 Earnings Call Highlights

International Flavors & Fragrances (IFF) reported Q3 sales of $566M in Health & Biosciences, up 1%. Full-year sales are expected to be $7.5B-$7.6B, with adjusted EBITDA of $1.55B-$1.6B. IFF faces cost pressures, particularly in Health & Biosciences, due to higher input costs. The company plans to divest its Food Ingredients business for $4.3B by mid-2027 and has completed other divestitures. Free cash flow for the first nine months of 2026 was $371M, up $245M year-over-year.

$IFFMed

International Flavors & Fragrances Inc (IFF) (Q3 2026) Earnings Call

International Flavors & Fragrances Inc (IFF) reported challenges in its Health business due to reduced consumer spending in the US and Europe. The company expects higher costs in Q4 2026, with net price to input costs remaining unfavorable. Profitability margins are expected to moderate due to seasonality and higher costs. IFF faces execution risks related to the separation of its Food Ingredients business.

$IFFHigh

BofA downgrades International Flavors & Fragrances stock rating on valuation concerns

BofA downgraded International Flavors & Fragrances (IFF) to Underperform, lowering its price target to $91. IFF reported Q3 adjusted EBITDA of $403M, beating estimates. Despite strong results, BofA cited valuation concerns, softness in non-Taste businesses, and rising costs. IFF's stock declined post-earnings due to near-term margin concerns, though management raised full-year guidance.

$IFFHighAI 8/10

Intl Flavors (IFF) Q3 2026 Earnings Call Transcript

Intl Flavors (IFF) reported Q3 2026 earnings with 5% revenue growth and 6% EBITDA increase, driven by strong performances in taste and scent segments. The company raised its full-year guidance, completed a $500M share repurchase, and announced strategic divestitures, including the sale of its food ingredients business for $4.3B. Free cash flow rose to $371M, up $245M YoY. IFF expects near-term softness in Health & Biosciences but remains confident in its growth strategy.

$IFFMedAI 9/10

IFF Q3 2026 slides: solid growth tempered by margin headwinds

International Flavors & Fragrances (IFF) reported Q3 2026 earnings with revenue of $1.94B and adjusted EPS of $0.83, beating expectations. Shares fell 3.83% due to margin concerns and guidance for softer Q4 profitability. IFF highlighted growth in Taste, Scent, and Health & Biosciences segments, along with a $4.3B sale of its Food Ingredients business and a $2.5B capital return program. Free cash flow improved to $371M, up $245M YoY.